Total Payments
$2,311
2024 Payments
$467.67
Companies
26
Transactions
134
Medicare Patients
4,908
Medicare Billing
$334,169
Payment Breakdown by Category
Food & Beverage$2,311 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,311 | 134 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $462.74 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $383.64 | 29 | $0 (2022) |
| Boston Scientific Corporation | $237.57 | 6 | $0 (2024) |
| Medtronic, Inc. | $170.96 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $128.50 | 9 | $0 (2019) |
| PFIZER INC. | $108.64 | 8 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $103.71 | 7 | $0 (2019) |
| Merck Sharp & Dohme LLC | $82.78 | 6 | $0 (2023) |
| Amarin Pharma Inc. | $78.38 | 6 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $70.96 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $467.67 | 19 | Boston Scientific Corporation ($191.17) |
| 2023 | $273.72 | 15 | Merck Sharp & Dohme LLC ($70.75) |
| 2022 | $195.02 | 3 | Medtronic, Inc. ($170.96) |
| 2021 | $95.03 | 7 | Janssen Pharmaceuticals, Inc ($79.62) |
| 2020 | $153.36 | 11 | Janssen Pharmaceuticals, Inc ($83.56) |
| 2019 | $469.88 | 35 | Janssen Pharmaceuticals, Inc ($123.45) |
| 2018 | $214.91 | 16 | Regeneron Healthcare Solutions, Inc. ($38.98) |
| 2017 | $441.02 | 28 | Novartis Pharmaceuticals Corporation ($143.46) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Coronary | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $16.53 | General |
| Category: Coronary | ||||||
| 10/01/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $16.37 | General |
| Category: Coronary | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $137.02 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/30/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Not Applicable | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 03/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/16/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/20/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $22.10 | General |
| Category: Cardiovascular Device | ||||||
| 10/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $34.64 | General |
| Category: Cardiovascular Device | ||||||
| 09/05/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,357 | 1,787 | $270,389 | $76,033 |
| 2022 | 10 | 1,459 | 1,929 | $292,246 | $81,656 |
| 2021 | 11 | 969 | 1,419 | $337,404 | $90,797 |
| 2020 | 11 | 1,123 | 1,556 | $358,225 | $85,683 |
Total Patients
4,908
Total Services
6,691
Medicare Billing
$334,169
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 315 | 461 | $113,461 | $31,954 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 238 | $86,223 | $23,398 | 27.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 134 | $32,031 | $9,018 | 28.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 591 | 727 | $7,423 | $5,024 | 67.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $12,658 | $2,804 | 22.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 174 | 187 | $10,867 | $2,069 | 19.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $7,726 | $1,766 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 273 | $98,902 | $28,499 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 293 | 416 | $102,386 | $28,347 | 27.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 75 | 162 | $38,724 | $9,831 | 25.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 555 | 721 | $7,465 | $5,126 | 68.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $14,859 | $3,381 | 22.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 222 | 240 | $13,946 | $2,848 | 20.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $11,816 | $2,674 | 22.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 23 | 23 | $1,679 | $410.13 | 24.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2022 | 23 | 23 | $1,121 | $273.95 | 24.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 16 | 18 | $1,346 | $265.86 | 19.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 339 | 527 | $132,360 | $36,940 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 183 | 239 | $87,754 | $25,372 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 89 | 257 | $61,433 | $15,990 | 26.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 35 | 39 | $17,724 | $4,360 | 24.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $16,927 | $3,788 | 22.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 136 | 142 | $8,252 | $1,712 | 20.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $5,088 | $912.69 | 17.9% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2021 | 32 | 33 | $2,409 | $559.51 | 23.2% |
About Dr. Anthony Losardo, M.D
Dr. Anthony Losardo, M.D is a Cardiovascular Disease healthcare provider based in West Paterson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982625182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Losardo, M.D has received a total of $2,311 in payments from pharmaceutical and medical device companies, with $467.67 received in 2024. These payments were reported across 134 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,311).
As a Medicare-enrolled provider, Losardo has provided services to 4,908 Medicare beneficiaries, totaling 6,691 services with total Medicare billing of $334,169. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location West Paterson, NJ
- Active Since 07/22/2006
- Last Updated 04/14/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1982625182
Products in Payments
- XARELTO (Drug) $383.64
- ENTRESTO (Drug) $357.50
- WATCHMAN FLX (Device) $191.17
- COREVALVE EVOLUT R (Device) $170.96
- ELIQUIS (Drug) $111.63
- LEQVIO (Drug) $105.24
- PRALUENT (Drug) $103.71
- PRALUENT ALIROCUMAB INJECTION (Biological) $100.90
- VERQUVO (Drug) $82.78
- Vascepa (Drug) $78.38
- PRADAXA (Drug) $70.66
- OPTIMIZER (Device) $56.74
- FFRct (Device) $49.01
- CHANTIX (Drug) $36.04
- ZIO XT Patch (Device) $34.17
- Lexiscan (Drug) $33.05
- VYNDAQEL (Drug) $31.93
- FARXIGA (Drug) $30.00
- PRALUENT (Biological) $27.60
- LifeVest (Device) $22.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in West Paterson
Dr. Warren Maresca, M.d, M.D
Cardiovascular Disease — Payments: $16,547
Cardiovascular Disease $16,547
Dr. John Capitanelli, M.d, M.D
Cardiovascular Disease — Payments: $15,964
Cardiovascular Disease $15,964
Dr. Raja'a Kaddaha, M.d, M.D
Cardiovascular Disease — Payments: $159.65
Cardiovascular Disease $159.65